Hot Investor Mandate: Family of VC Funds Actively Invest in Therapeutics, Medical Devices, Diagnostics, with Focus on Pre-Clinical and Early Clinical Products

30 May

An international family of venture capital funds that invests in early-stage, high-growth life science and health technology companies in the US, UK, and Europe. The firm invests via a two fund structure, and is currently investing out of one Europe-based fund, and is actively raising a USA fund to focus on investing in USA-based companies. The EU fund primarily provides Series A financing in the range of £2-5M. The EU fund is actively seeking new investment opportunities in the UK and Europe. In the USA, Epidarex is interested in Seed and Series A opportunities.

The firm is currently seeking to invest in novel early stage biotech therapeutic and diagnostic, medical devices and pharmaceuticals. The firm is opportunistic in terms of subsectors and indications. The firm is also interested in other areas such as personalized medicine, healthcare IT and services. For therapeutics, the firm focuses on products in pre-clinical and early clinical and will consider orphan indications.

The firm requests a board seat in each portfolio company. The firm invests in management teams who are highly driven and tenacious problem solvers.

If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: